Kiniksa Pharmaceuticals, Ltd. (KNSA) has a market capitalization of $3.48B and trades at $46.92. The 52-week range is 18.255-49.329.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 58.7, Earnings Per Share (EPS) of $0.80, annual revenue of $677.56M.
The stock has a beta of 0.06, operates in the Healthcare sector.
